Efficacy of Low-Dose Captopril Given Twice Daily to Patients with Essential Hypertension Uncontrolled by a Beta Blocker plus Thiazide Diuretic
- 30 June 1984
- journal article
- research article
- Published by SAGE Publications in Journal of International Medical Research
- Vol. 12 (4), 221-228
- https://doi.org/10.1177/030006058401200401
Abstract
Thirty-two patients with moderate to severe essential hypertension whose supine diastolic blood pressure (SDBP) was ⩾95 mm Hg following 2 weeks' treatment with the optimal dosage of beta blocker-diuretic combination were randomly assigned to the addition of either Captopril 25 mg or 50 mg b.i.d. After 6 weeks' treatment, if patients were not normalized (SDBP The addition of Captopril led to a significant fall in standing and supine diastolic and systolic blood pressure at the end of the sixth and twelfth week of treatment. There was no difference in the change in blood pressure between the two groups. At the end of the study SDBP was normalized in 66% of patients and a further 12·5% had their SDBP reduced by >10%. Captopril 25 or 50 mg administered twice daily proved to be a very effective antihypertensive agent when added to a beta blocker-diuretic combination in patients resistant to optimal doses of these drugs.This publication has 15 references indexed in Scilit:
- "Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.BMJ, 1984
- Factors related to first dose hypotensive effect of captopril: prediction and treatment.BMJ, 1983
- Clinical experience with captopril in the treatment of severe drug-resistant hypertensionThe American Journal of Cardiology, 1982
- Acute and chronic effects of the angiotensin-converting enzyme inhibitor captopril in severe hypertensionThe American Journal of Cardiology, 1982
- Long-term efficacy of captopril in renovascular and essential hypertensionThe American Journal of Cardiology, 1982
- Angiotensin-converting enzyme inhibition, catecholamines and hemodynamics in essential hypertensionThe American Journal of Cardiology, 1982
- Angiotensin-converting enzyme inhibition: A developing therapeutic concept: Introduction to session I: DevelopmentThe American Journal of Cardiology, 1982
- Essential hypertension: effect of an oral inhibitor of angiotensin-converting enzyme.BMJ, 1979
- Oral Angiotensin-Converting Enzyme Inhibitor in Long-Term Treatment of Hypertensive PatientsAnnals of Internal Medicine, 1979
- Converting enzyme inhibition with an orally active compound in hypertensive man.Hypertension, 1978